Protective effects of tungstophosphoric acid and sodium tungstate on chemically induced liver necrosis in Wistar rats

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 10, Issue 3, 2007, Pages 340-349

  Uskoković Marković, Snežana ^a   Milenković, Marina ^a   Topić, Aleksandra ^a   Kotur Stevuljević, Jelena ^a   Stefanović, Aleksandra ^a   Antić Stanković, Jelena ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ANTIOXIDANT; ASPARTATE AMINOTRANSFERASE; CARBON TETRACHLORIDE; GLUTATHIONE; LIVER ENZYME; MALONALDEHYDE; PHOSPHOTUNGSTIC ACID; SUPEROXIDE; THIOACETAMIDE; TUNGSTATE SODIUM; TUNGSTEN DERIVATIVE; UNCLASSIFIED DRUG; XANTHINE OXIDASE; 12 TUNGSTOPHOSPHORIC ACID; 12-TUNGSTOPHOSPHORIC ACID; PHOSPHORIC ACID; SODIUM TUNGSTATE(VI);

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; HISTOPATHOLOGY; INFLAMMATORY CELL; LIVER CELL; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; NONHUMAN; RAT; ACUTE DISEASE; ANIMAL; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; DRUG EFFECT; LIVER; LIVER FUNCTION TEST; METABOLISM; NECROSIS; ORAL DRUG ADMINISTRATION; OXIDATIVE STRESS; PATHOLOGY; PATHOPHYSIOLOGY; WISTAR RAT;

ACUTE DISEASE; ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; FEMALE; GLUTATHIONE; LIVER; LIVER FUNCTION TESTS; NECROSIS; OXIDATIVE STRESS; PHOSPHORIC ACIDS; RATS; RATS, WISTAR; THIOACETAMIDE; TUNGSTEN COMPOUNDS;

EID: 34848897541     PISSN: None     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Lee WR. Acute liver failure. N Engl J Med 1993; 329: 1862-1872.
2. Williams AT, Burk RF. Carbon tetrachloride hepatotoxicity: an example of free radical-mediated injury. Seminars in Liver Disease 1990; 10: 279-284.
3. Recknagel RO, Glende EE, Dolak JA, Waller RL. Mechanism of carbon tetrachloride toxicity. Pharmacol Ther 1989; 43: 134-154.
4. Porter WR, Neal RA. Metabolism of thioacetamide and thioacetamide S-oxide by rat liver microsomes. Drug Metab Dispos 1978; 6: 379-388.
5. Ali S, Diwakar G, Pawa S, Siddiqui, MR, Jain SK, Abdulla M. Attenuation by boron supplementation of the biochemical changes associated with thioacetamide-induced hepatic lesions. Trace Elem Exp Med 2002; 15: 47-55.
6. Delgado O, Dress A, Müller A, Pope MT. Polyoxometalates: A class of compounds with remarkable topology. In: Pope MT, Müller A, ed. Polyoxometalates: From Platonic Solids to Anti-Retroviral Activity, Kluwer Academic Publishers, Dordrecht, 1994.
7. Rhule J, Hill C, Judd D, Schinazi R. Polyoxometalates in medicine. Chem Rev 1998; 98: 327-357.
8. Rehder D. The coordination chemistry of vanadium as related to its biological functions. Coord Chem Rev 1999; 182: 297-322.
9. Stankiewicz PJ, Tracey AS, Crans DC. Vanadium and its role in life. In: Sigel H, Sigel A, ed. Metal Ions in Biological Systems, vol.31, Marcel Dekker, New York, 1995.
10. Tajima Y. A review of the biological and biochemical effects of tungsten compounds. Curr Top Biochem Res 2001; 4: 129-136.
11. Yamase T, Fukuda N, Tajima Y. Synergistic effect of polyoxotungstates in combination with β-lactam antibiotics on antibacterial activity against methicillin-resistant Staphylococcus aureus. Biol Pharmacol Bull 1996; 19: 459-465.
12. Jelikić-Stankov M, Uskoković-Marković S, Holclajtner-Antunović I, Todorović M, Djurdjević P. Compounds of Mo, V and W in biochemistry and their biomedical activity. J Trace Elem Med Biol 2007; 21: 8-16.
13. Greenwood NN, Earnshaw A. Chemistry of the Elements. Pergamon, New York, 1984.
14. Matsumoto J. Vanadate, molybdate and tungstate for orthomolecular medicine. Med Hypotheses 1994; 43: 177-82.
15. Fessenden-Raden JM. Effect of silicotungstate on reduced diphosphopyridine nucleotide oxidation in submitochondrial Particles. J Biol Chem 1971; 246: 6745-6749.
16. Pitt RM, McKelvey TG, Saenger JS, Shah AK, Jones HP, Manci EA, Powell RW. A tungsten-supplemented diet delivered by transplacental and breast-feeding routes lowers intestinal xanthine oxidase activity and affords cytoprotection in ischemia-reperfusion injury to the small intestine. J Pediatr Surg 1991; 26: 930-935.
17. Hwang PL, Ryan RJ. Tungstate stimulates adenylate cyclase. Endocrinology 1981; 108: 435-439.
18. May HD, Patel PS, Ferry JG. Effect of molybdenum and tungsten on synthesis and composition of formate dehydrogenase in methanobacterium formicicum. J Bacteriol 1988; 170: 3384-3389.
19. Foster JD, Young SE, Brandt TD, Nordlie RC. Tungstate: A potent inhibitor of multifunctional glucose-6-phosphatase. Arch Biochem Biophys 1998; 354: 125-132.
20. Barbera A, Gomis RR, Prats N, Rodriguez-Gil JE, Domingo M, Gomis R, Guinovart JJ. Tungstate is an effective, antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study. Diabetologia 2001; 44: 507-513.
21. Claret M, Corominola H, Canals I, Saura J, Barcelo-Batllori S, Guinovart JJ, Gomis R. Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation. Endocrinology 2005; 146: 4362-4369.
22. Pawa S, Ali S. Liver necrosis and fulminant hepatic failure in rats: protection by oxyanionic form of tungsten. Biochim Biophys Acta 2004; 1688: 210-222.
23. Girotti MJ, Khan N, McLellan BA. Early measurement of systemic lipid peroxidation products in plasma of major blunt trauma patients. J Trauma 1991; 31: 32-35.
24. Auclair C, Voisin E. Nitroblue tetrazolium reduction. In: Greenwald RE, ed. CRC Handbook of Methods for Oxygen Radical research. Boca Raton, CRC Press, FL, 1985.
25. Jollow DJ, Mitchell JR, Zampaglione N, Gillette JR. Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 1974; 11: 151-169.
26. Stirpe F, Della Corte E. The regulation of rat liver xanthine oxidase. Conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxydase (type O). J Biol Chem 1969; 244: 3855-3863.
27. Bradford MM. A rapid and sensitive method for the quantitation of the microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976; 72: 248-254.
28. Kang KW, Choi SH, Ha JR, Kim CW, Kim SG. Inhibition dimethylnitrosamine-induced liver fibrosis by [5-(2-pyrazynil)-4-methyl-1,2-dithiol-3-thione] (oltipraz) in rats: suppression of transforming growth factor- beta 1 and tumor necrosis factor-alpha expression. Chem Biol Interac 2002; 139: 61-77.
29. De Ferreiyra EC, Bernacchi AS, San Martin MF, Castro GD, Castro JA. Trifluopromazine late preventive effects on Carbon Tetrachloride-Induced Liver Necrosis. Exp Mol Plathol 1995; 62: 75-82.
30. McNally JS, Davis ME, Giddens DP, Saha A, Hwang J, Dikalov S, Jo H, Harrison DG. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am J Physiol Heart Circ Physiol 2003; 285: 2290-2297.
31. Johnson JL, Rajagopalan KV, Cohen HJ. Effect of tungsten on xanthine oxidase and sulfitr oxidase in the rat. J Biol Chem 1974; 249: 859-866.
32. Higgins ES, Richert DA, Westerfeld WW. Molybdenum deficiency and tungstate inhibition studies. J Nutr 1956; 59: 539-559.
33. Fang YZ, Yang S, Wu G. Free radicals, antioxidants, and nutrition. Nutrition 2002; 18: 872-879.
34. Lauterburg BH. Analgesics and glutathione. Am J Ther 2002; 9: 225-233.
35. Comporti M, Macllaro E, Del Bello B, Casini AF. Glutathione depletion: its effects on other antioxidant systems and hepatocellular damage. Xenobiotica 1991; 21: 1067-1076.